- RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist. Bonhaus, D.W., Weinhardt, K.K., Taylor, M., DeSouza, A., McNeeley, P.M., Szczepanski, K., Fontana, D.J., Trinh, J., Rocha, C.L., Dawson, M.W., Flippin, L.A., Eglen, R.M. Neuropharmacology (1997)